Halo Pharma is a leading provider of pharmaceutical services, including contract dosage form development, commercial manufacturing, and analytical services.

Like our customers, we are passionate about making a difference in the lives of patients. We leverage our expertise to bring our customers’ products through the development, regulatory, and manufacturing process so that they are available for patients who need them.

Halo Pharma’s capabilities in the areas of tech transfer, process and pharmaceutical product development, formulation development, production, scale-up and validation, and analytical method development allow us to partner with clients from development through commercialization or at any point along the way. Our expertise across many dosage forms, including complex oral solids, topicals, oral solutions and suspensions and the manufacture of controlled substances is unmatched in North America. Halo Pharma serves a growing global customer base across multiple regulatory environments. These attributes allow Halo Pharma to be a partner of choice for many of today’s large pharma, generic pharma and biotech pharma companies.

While we excel at all of our scientific and manufacturing know-how, we strive to be the best partner. We are collaborative and responsive, working with customers to find effective and expedient solutions to their pharmaceutical development and manufacturing challenges. We are engaged and always exploring new ideas and approaches. We are agile and flexible and can easily accommodate changes that may arise in the needs of a customer’s project, at any point in a product’s life cycle.

Halo Pharma is part of the Noramco Group.